Elias A Said1, Iman Al-Reesi2, Nawal Al-Shizawi2, Sanjay Jaju3, Mohammed S Al-Balushi1, Crystal Y Koh1, Ali A Al-Jabri1, Lakshmanan Jeyaseelan4. 1. Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khoudh, Sultanate of Oman. 2. Department of Microbiology, Suhar Hospital, Sohar, Sultanate of Oman. 3. Department of Family Medicine and Public Health, College of Medicine and Health Sciences Sultanate of Oman, Alkoudh, Sultanate of Oman. 4. Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India.
Abstract
BACKGROUND: Interleukin-6 (IL-6) is produced by and impacts different cell types in human. IL-6 is associated with different diseases and viral infections, including COVID-19. To our knowledge, no normal values were reported for IL-6 in the blood of healthy individuals. We have reviewed and performed a meta-analysis on a total of 140 studies, including 12,421 values for IL-6 in the blood of healthy adult donors. Among these studies, 83 did not report a mean value and the standard deviation. Therefore, for the statistical analysis, we used the values reported in 57 studies, which included 3166 values for IL-6. RESULTS: The reported values for IL-6 in the blood of healthy donors varied between 0 and 43.5 pg/ml. The pooled estimate of IL-6 was 5.186 pg/ml (95% confidence interval [CI]: 4.631, 5.740). As the age increased by 1 year, IL-6 values increased by 0.05 pg/ml (95% CI: 0.02, 0.09; p < .01). Though the heterogenicity, as determined by I2 statistics, was high in our study, the differences in IL-6 values are still at the level of a few pg/ml, which might be related to the differences in the conditions that influence IL-6 production in the healthy population. CONCLUSIONS: This is the first meta-analysis reporting the levels of IL-6 in the blood of healthy donors based on a large number of studies and donors. Therefore the 95% CI values determined in our study could well serve as a reference range for quick decision-making in clinical interventions, particularly those aiming to inhibit IL-6, especially urgent interventions, for example, COVID-19.
BACKGROUND:Interleukin-6 (IL-6) is produced by and impacts different cell types in human. IL-6 is associated with different diseases and viral infections, including COVID-19. To our knowledge, no normal values were reported for IL-6 in the blood of healthy individuals. We have reviewed and performed a meta-analysis on a total of 140 studies, including 12,421 values for IL-6 in the blood of healthy adult donors. Among these studies, 83 did not report a mean value and the standard deviation. Therefore, for the statistical analysis, we used the values reported in 57 studies, which included 3166 values for IL-6. RESULTS: The reported values for IL-6 in the blood of healthy donors varied between 0 and 43.5 pg/ml. The pooled estimate of IL-6 was 5.186 pg/ml (95% confidence interval [CI]: 4.631, 5.740). As the age increased by 1 year, IL-6 values increased by 0.05 pg/ml (95% CI: 0.02, 0.09; p < .01). Though the heterogenicity, as determined by I2 statistics, was high in our study, the differences in IL-6 values are still at the level of a few pg/ml, which might be related to the differences in the conditions that influence IL-6 production in the healthy population. CONCLUSIONS: This is the first meta-analysis reporting the levels of IL-6 in the blood of healthy donors based on a large number of studies and donors. Therefore the 95% CI values determined in our study could well serve as a reference range for quick decision-making in clinical interventions, particularly those aiming to inhibit IL-6, especially urgent interventions, for example, COVID-19.
Authors: Eric D Morrell; Pavan K Bhatraju; Neha A Sathe; Jonathan Lawson; Linzee Mabrey; Sarah E Holton; Scott R Presnell; Alice Wiedeman; Carolina Acosta-Vega; Mallorie A Mitchem; Ted Liu; Xin-Ya Chai; Sharon Sahi; Carolyn Brager; Marika Orlov; Sana S Sakr; Anthony Sader; Dawn M Lum; Neall Koetje; Ashley Garay; Elizabeth Barnes; Gail Cromer; Mary K Bray; Sudhakar Pipavath; Susan L Fink; Laura Evans; S Alice Long; T Eoin West; Mark M Wurfel; Carmen Mikacenic Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-05-24 Impact factor: 6.011
Authors: Kristina R Gopcevic; Eugenia Gkaliagkousi; János Nemcsik; Ömür Acet; M Rosa Bernal-Lopez; Rosa M Bruno; Rachel E Climie; Nikolaos Fountoulakis; Emil Fraenkel; Antonios Lazaridis; Petras Navickas; Keith D Rochfort; Agnė Šatrauskienė; Jūratė Zupkauskienė; Dimitrios Terentes-Printzios Journal: Front Physiol Date: 2021-12-14 Impact factor: 4.566
Authors: Ji Hyun Kim; Denethia S Green; Young Min Ju; Mollie Harrison; J William Vaughan; Anthony Atala; Sang Jin Lee; John D Jackson; Cory Nykiforuk; James J Yoo Journal: Front Bioeng Biotechnol Date: 2022-07-22
Authors: Reece Jefferies; Harish Puttagunta; Anoushka Krishnan; Ashley Irish; Ramyasuda Swaminathan; John K Olynyk Journal: Front Med (Lausanne) Date: 2022-02-22